Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Autologous Tissue Repair Becoming a Key Practice Area

Autologous Tissue Repair Becoming a Key Practice Area in Personalized Medicine

Greystone Research Associates Identifies Process and Outcome Improvements as Key Market Drivers

(Amherst, NH) – The ability to isolate, purify and re-inject patient-derived cells with regenerative properties has led to a number of therapeutic products for the treatment of refractory injuries and wounds. Autologous therapies are having an impact on a number of areas, including cardiovascular medicine, refractory wound care, orthopedics, and surgical medicine.

Applications for patient-derived tissue repair are expanding beyond traditional refractory wound care markets to encompass a growing list of surgical procedures and orthopedic restoration applications. The market for autologous tissue repair will continue to grow at an increasing rate due to favorable demographics. More than two-dozen autologous tissue repair products are currently being marketed or are in development, several with the potential to have a significant impact on regenerative medicine.

The potential economic benefits of autologous treatments are significant, as an aging population struggles with intractable ailments that historically have required numerous follow-up provider visits. While several approved autologous products require remote processing, the number of autologous therapeutics that can be processed at the point-of-care is increasing. Twenty-seven separate companies worldwide have products and development programs for autologous tissue repair – companies working to shape the future of tissue regeneration.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

These findings are contained in a new and comprehensive report: Autologous Tissue Repair to 2018: Products, Indications, Markets and Forecasts. The report contains in-depth analysis of patient-derived therapies, clinical trial activities and prospects for therapeutic indications that include orthopedics, cardiovascular medicine, surgical procedures, and wound care.
More information is available at
http://www.greystoneassociates.org

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.